Penumbra
PEN
#1749
Rank
โ‚ฌ9.80 B
Marketcap
250,33ย โ‚ฌ
Share price
-1.27%
Change (1 day)
9.81%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.33 Billion

According to Penumbra's latest financial reports the company's total liabilities are โ‚ฌ0.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.36 B7.61%
2023-12-31โ‚ฌ0.34 B-1.57%
2022-12-31โ‚ฌ0.34 B35.29%
2021-12-31โ‚ฌ0.25 B70.26%
2020-12-31โ‚ฌ0.15 B-6.44%
2019-12-31โ‚ฌ0.16 B98.85%
2018-12-31โ‚ฌ80.93 M27.35%
2017-12-31โ‚ฌ63.55 M60.29%
2016-12-31โ‚ฌ39.65 M38.4%
2015-12-31โ‚ฌ28.65 M-73.95%
2014-12-31โ‚ฌ0.10 B91.74%
2013-12-31โ‚ฌ57.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Inari Medical
NARI
โ‚ฌ0.22 B-31.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
โ‚ฌ0.94 B 185.63%๐Ÿ‡บ๐Ÿ‡ธ USA